Crossmark

Mantle cell lymphoma transformation to CD19-negative classic Hodgkin lymphoma as a novel mechanism of escape from CD19 chimeric antigen receptor T cell therapy

Crossref DOI link: https://doi.org/10.1007/s12308-025-00675-1

Published Online: 2025-12-10

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Yu

Bayerl, Michael

Mineishi, Shin

Washburn, Erik
License Information

Text and Data Mining valid from 2025-12-01

Version of Record valid from 2025-12-01
More Information

Article History

Received: 26 September 2025

Accepted: 2 December 2025

First Online: 10 December 2025

Declarations

:

: The authors declare no competing interests.

: For this type of study, formal consent is not required. The Institutional Review Board (IRB) does not require IRB approval for publication of case reports or images.

: For this type of study, informed consent is not required.

: Consent for publication was obtained from the patient included in the report.

Document is current

Any future updates will be listed below